ARTV - Artiva Biotherapeutics, Inc.
2.1
0.180 8.571%
Share volume: 188,829
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.92
0.18
0.09%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 08-29-2024 | 11-12-2024 | 08-29-2024 | 11-12-2024 | 03-24-2025 | |
| Total revenue | 3.497 M | 26.656 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 3.497 M | 26.656 M | 0.000 | 0.000 | 0.000 | |
| 662.25% | -100.00% | nan% | nan% | |||
| Operating expenses | 15.321 M | 15.845 M | 16.190 M | 18.335 M | 0.000 | |
| Selling general and admin | 4.059 M | 2.780 M | 3.857 M | 4.811 M | 0.000 | |
| Research and development | 11.262 M | 13.065 M | 12.333 M | 13.524 M | 0.000 | |
| Total expenses | 15.321 M | 15.845 M | 16.190 M | 18.335 M | 0.000 | |
| 3.42% | 2.18% | 13.25% | -100.00% | |||
| Operating income | -11.824 M | 10.811 M | -16.190 M | -18.335 M | 0.000 | |
| Ebit | -11.793 M | 10.861 M | -18.542 M | -19.312 M | 0.000 | |
| Pretax income | -11.284 M | 11.279 M | -17.866 M | -17.466 M | 0.000 | |
| -199.96% | -258.40% | -2.24% | -100.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.284 M | 11.279 M | -17.843 M | -17.472 M | 0.000 | |
| 199.96% | -258.20% | 2.08% | 100.00% |
